Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Part Study of CLE-100 as an Adjunct Therapy in Subjects With Major Depressive Disorder

NCT04103892 is registered in ClinicalTrials.gov with Clexio Biosciences Ltd. as lead sponsor.

NCT NCT04103892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04103892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Part Study of CLE-100 as an Adjunct Therapy in Subjects With Major Depressive Disorder
Lead sponsor
Clexio Biosciences Ltd.
Phase
Phase 2
Overall status
Completed
Start date
September 5, 2019
Completion date
October 5, 2022
Enrollment
146 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

adjunctive treatment of major depressive disorder